Fundraising Fox

Anís

Investor

Head of Scoping, Pharma at Deep Science Ventures

London, England, United Kingdom

About

Biopharma researcher and Oxford Clarendon Scholar with a PhD in breast cancer immunology using single-cell genomics; helps build curative therapeutics companies at DSV.

Experience

  1. NovartisDirector, R&D Strategic Insightscurrent2026 — presentLondon, England, United Kingdom
  2. Kindling BioBoard Member2026London Area, United Kingdom
  3. Stealth Mode BiotechVP Biology & Program Lead2026Cambridge, England, United Kingdom
  4. Stealth Mode BiotechOrigination Lead2024 — 2025Cambridge, England, United Kingdom
  5. Flip TherapeuticsCo-Founder & Operating Partner | Board Observer2025 — 2026Cambridge, Massachusetts, United States
  6. Flip TherapeuticsOrigination Lead2023 — 2024Cambridge, Massachusetts, United States
  7. Deep Science VenturesPrincipal (Head of Scoping) — Pharmaceuticals2024 — 2026Greater London, England, United Kingdom
  8. Deep Science VenturesSenior Associate – Pharmaceuticals2022 — 2023Greater London, England, United Kingdom
  9. Deep Science VenturesAssociate – Pharmaceuticals2022Greater London, England, United Kingdom
  10. Deep Science VenturesAnalyst – Pharmaceuticals2020 — 2022Greater London, England, United Kingdom
  11. Deep Science VenturesFellow – Pharmaceuticals2020Greater London, England, United Kingdom
  12. Self-employedFreelance Consultant2025
  13. University of OxfordPhD Candidate & Clarendon Scholar – Kennedy Institute2017 — 2021
  14. University of OxfordMSc Candidate – Nuffield Department of Experimental Medicine2017
  15. UCBResearch Associate – Immunology Therapeutic Area2015 — 2016Slough, United Kingdom
  16. Boehringer IngelheimResearch Scientist Trainee – New Therapeutic Concepts (Oncology)2013 — 2014Vienna, Austria
  17. Lonza BiologicsAuditor – Quality Assurance2012Slough, United Kingdom
  18. Lonza BiologicsDocument Administrator – Quality Assurance2010 — 2011Slough, England, United Kingdom

Education

  1. University of OxfordDoctor of Philosophy (DPhil/PhD), Molecular and Cellular Medicine2017 — 2021
  2. University of OxfordMaster of Science (MSc), Integrated Immunology2016 — 2017
  3. The University of ManchesterBachelor of Science (BSc) (Hons), Biochemistry with Industrial Experience2011 — 2015

Skills & more

Program ManagementLead OptimisationPre-clinical StudiesPharmacokineticsProtein EngineeringTechnology EvaluationProgram LeadershipIn-licensingCRO ManagementCorporate GovernanceBoard of DirectorsBoard of Directors Reporting
+12 moreCorporate FundraisingTerm SheetsConsultancy ServicesFreelancingConsultingStatisticsHigh Performance Computing (HPC)ProgrammingLeadershipTeam ManagementPlatform OperationsTranslational Strategy

Languages English · French · German

  • Role of the Board Director (Training Course) — The Chartered Governance Institute UK & Ireland
  • Personal Licence — UK Home Office

From Anís's professional profile.

Colleagues at Deep Science Ventures

Aaron
Head of Programme, Education at Deep Science Ventures
Adam
Senior Director, Climate at Deep Science Ventures
Ahmad
Executive Chairman at Deep Science Ventures
Ashraf
Fractional Director, Computation at Deep Science Ventures
Claire
Venture Partner, Education at Deep Science Ventures
Dom
Founding Director at Deep Science Ventures
Francesco
Head of ML Engineering at Deep Science Ventures
Harry
Senior Associate, Climate at Deep Science Ventures

Frequently asked questions

Where does Anís work?
Anís is Head of Scoping, Pharma at Deep Science Ventures.

Same school

Also attended University of Oxford950

Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter Capital; architect of Invest America; BG2 co-hostDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures

+ 944 more

Also attended The University of Manchester163

Joel NoyceInvestor at Moonfire VenturesJames BraithwaiteFinancial Controller at NorthzoneFreya Svedberg-KeatingInvestor at MedicxiAndy LeaverOperating Partner at Notion CapitalSimon SegarsExecutive Advisor at Black Opal VenturesHonor de WintonExecutive Assistant at Giant Ventures Global Llp

+ 157 more

Shared employers

Also worked at Deep Science Ventures23

Saran DaviesInvestor at Moonfire VenturesAlistair OwenPrincipal at VentureFriendsJustin BriggsPartner & VP of Biology at Prime Movers LabFrank HicksImpact Committee at EcoEnterprises FundDomFounding Director at Deep Science VenturesSantaDirector, Talent at Deep Science Ventures

+ 17 more

Also worked at University of Oxford114

Tess van StekelenburgPartner at Lux CapitalGordon RausserAdvisory Board Member at Rembrandt Venture PartnersFrancesco MonacaInvestor at Giant Ventures Global LlpDenise XifaraInvestor at Mercuri.vcLirui DingPrincipal at TRANSCENDAna FernandezInvestment Associate at Nauta Capital

+ 108 more

Also worked at UCB14

Stephen RapeckiInvestor at MedicxiMiguel ForteAdvisor at Delin VenturesJohn LeonardExecutives in Residence at GENERAL INCEPTIONLaia CrespoPartner at Sanofi VenturesCaroline GoddeerisPartner at Fund+Charles-Antoine JanssenManaging Partner at HealthQuad

+ 8 more

Also worked at Boehringer Ingelheim26

Drew GonzalesInvestor at Side Door VenturesKazu NonomuraPartner, Director at RDiscoveryShinobu SuzukiScientific Advisor at RDiscoveryDhiren PatelDigital Pharma Advisor at Excelerate Health VenturesPeter FarinaExecutive in Residence at Canaan PartnersMarcel ZijpSenior Investment Manager at Brightlands Venture Partners

+ 20 more